Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone

International Journal of Pharmaceutics

Volumn 200, Issue 1, 2000, Pages 127-132

  Lopez, Renata F V ^a   Collett, John H ^b   Bentley, M Vitória L B ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cyclodextrin; In vitro skin permeation; Inclusion complexes; Skin metabolism

Indexed keywords

CYCLODEXTRIN; DEXAMETHASONE;

ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ABSORPTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BETA-CYCLODEXTRINS; BUFFERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLODEXTRINS; DEXAMETHASONE; EXCIPIENTS; MICE; MICE, INBRED HRS; SKIN; SKIN ABSORPTION;

EID: 0034712799     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(00)00365-3     Document Type: Article

References (14)

1. Arima H., Miyaji T., Irie T., Hirayama F., Uekama K. Enhancing effect of hydroxypropyl-beta-cyclodextrin on cutaneous penetration and activation of ethyl-4-biphenyl acetate in hairless mouse skin. Eur. J. Pharm. Sci. 6:1998;53-59.
2. Arima H., Miyaji T., Irie T., Hirayama F., Uekama K. Possible enhancing mechanism of the cutaneous permeation of 4-biphenylylacetic acid by beta-cyclodextrin derivatives in hydrophilic ointment. Chem. Pharm. Bull. 44:1996;582-586.
3. Barry B.W. Dermatological Formulations. Percutaneous Absorption. Drugs And The Pharmaceutical Sciences. 1983;Marcel Dekker, New York.
4. Bast G.E. Influence of solubility and permeant size on metabolism of xenobiotics in rabbit skin. Hum. Exp. Toxicol. 16:1997;435-440.
5. Bentley M.V.L.B., Vianna R.F., Wilson S., Collett J.H. Characterization of the influence of some cyclodextrins on the stratum corneum from the hairless mouse. J. Pharm. Pharmacol. 49:1997;397-402.
6. Legendre J.Y., Rault I., Luijten W. et al. Effects of (-cyclodextrins on skin: implications for the transdermal delivery of piribedil and a novel cognition enhancing-drug. Eur. J. Pharm. Sci. 3:1995;311-322.
7. Lemesle-Lamache V., Wouessidjewe D., Chéron M., Duchêne D. Study of (-cyclodextrin and ethylated (-cyclodextrin salbutamol complexes, in vitro evaluation of sustained-release behaviour of salbutamol. Int. J. Pharm. 141:1996;117-124.
8. Másson M., Loftsson T., Másson G., Stefánsson E. Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing. J. Control. Release. 59:1999;107-118.
9. Phillips C.A., Michniak B.B. Transdermal delivery of drugs with differing lipophilicities using azone analog as dermal penetration enhancers. J. Pharm. Sci. 84:1995;1427-1433.
10. Potts R.O., McNeill S.C., Desbonnet C.R., Wakshull E. Transdermal drug transport and metabolism II: the role of competing kinetc events. Pharm. Res. 6:1989;119-124.
11. Sapan C.V., Lundblad R.L., Price N.C. Colorimetric protein assay techniques. Biotechnol. Appl. Biochem. 2:1999;99-108.
12. Singh P., Roberts M.S. Skin permeability and local tissue concentrations of nonsteroidal anti- inflamatory drugs after topical application. J. Pharmacol. Exp. Ther. 268:1994;144-151.
13. Vianna R.F.L., Bentley M.V.L.B., Ribeiro G. et al. Formation of cyclodextrin inclusion complexes with corticosteroids: their characterization and stability. Int. J. Pharm. 167:1998;205-213.
14. Williams A.C., Shatri S.R.S., Barry B.W. Transdermal permeation inhibition by cyclodextrins. Pharm. Res. 13:1996;379.